NCT05252416 2025-11-28(VELA) Study of BLU-222 in Advanced Solid TumorsBlueprint Medicines CorporationPhase 1 Terminated50 enrolled
NCT05867251 2025-11-19Study of AVZO-021 in Patients With Advanced Solid TumorsAvenzo Therapeutics, Inc.Phase 1/2 Recruiting430 enrolled